SECTION FOR 406 IPC - AN OVERVIEW

secobarbital will minimize the extent or effect of cannabidiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Carefully. Consider a rise in cannabidiol dosage (depending on medical reaction and tolerability) when coadministered with a solid CYP3A4 inducer.The effect from the resultant lessened blood levels of grise